Below is the edited excerpt of the interview:
Q: Was it a conscious decision to remain small in India because a lot of MNC chiefs that I speak to off the record tell me that India is a difficult place to do business in?
A: India is a difficult place to do business in, but in today's world almost any place is difficult. We have a very good team in India and I am very confident that we will be making lot of progress and are actually growing very fast.
Q: Were you the fastest growing MNC in India last year?
A: We have been growing twice as fast as the market. We have important products to offer to the Indian healthcare system. We are catching up to some degree in India. For us, India is also attractive in the sense that there are many important scientific developments coming out of India, we have partnerships with quite a few Indian companies. We are sourcing technology.
Q: How do you react to certain policy decisions like doing clinical trials in India has suddenly become very difficult? Has that put a halt to your clinical trials in India?
A: It has made it much more difficult. We think that certain technicalities should be reviewed. We think it is a good initiative to strengthen patient protection. At the same time the technicalities of the law should be adapted to international standards.
Q: Have clinical trials come to halt in India?
A: We have deprioritised India as a research hub right now. We are waiting to see whether the regulations will be adapted to the international standards.
Anda sedang membaca artikel tentang
'India difficult place for biz, yet confident of progress'
Dengan url
https://kesehatanda.blogspot.com/2014/01/india-difficult-place-for-biz-yet.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
'India difficult place for biz, yet confident of progress'
namun jangan lupa untuk meletakkan link
'India difficult place for biz, yet confident of progress'
sebagai sumbernya
0 komentar:
Posting Komentar